​
​

Sunshine Biopharma (SBFM) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Sunshine Biopharma Revenue Highlights

Latest Revenue (Y)

$39.85M

Latest Revenue (Q)

$9.30M

Sunshine Biopharma Revenue by Period

Sunshine Biopharma Revenue by Year

DateRevenueChange
2023-12-31-816.94%
2022-12-31-1802.41%
2021-12-31-219.88%
2020-12-31-238.10%
2019-12-31--95.28%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-07-31-100.00%
2007-07-31--

Sunshine Biopharma generated $39.85M in revenue during NA 2023, up 816.94% compared to the previous quarter, and up 8910.20% compared to the same period a year ago.

Sunshine Biopharma Revenue by Quarter

DateRevenueChange
2024-06-30-23.37%
2024-03-31--1.81%
2023-12-31-28.91%
2023-09-30-7.14%
2023-06-30-13.62%
2023-03-31-24.22%
2022-12-31-2866.57%
2022-09-30--11.64%
2022-06-30-22.55%
2022-03-31-44.09%
2021-12-31-68.97%
2021-09-30--4.72%
2021-06-30-31.99%
2021-03-31-43.00%
2020-12-31-63.34%
2020-09-30-13.24%
2020-06-30-36.42%
2020-03-31-5.17%
2019-12-31-44.09%
2019-09-30-141.54%
2019-06-30--97.47%
2019-03-31-7.05%
2018-12-31--18.33%
2018-09-30-27.68%
2018-06-30-17.64%
2018-03-31-171.33%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30--100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-10-31-100.00%
2009-07-31-100.00%
2009-04-30-100.00%
2009-01-31-100.00%
2008-10-31-100.00%
2008-07-31-100.00%
2008-04-30--

Sunshine Biopharma generated $9.30M in revenue during Q2 2024, up 23.37% compared to the previous quarter, and up 190.09% compared to the same period a year ago.

Sunshine Biopharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PTPIPetros Pharmaceuticals--
PAHCPhibro Animal Health--
EGRXEagle Pharmaceuticals--
LFCRLifecore Biomedical--
ALIMAlimera Sciences--
DERMJourney Medical--
SBFMSunshine Biopharma--
TKNOAlpha Teknova--
SNOASonoma Pharmaceuticals--
GHSIGuardion Health Sciences--
SSICSilver Spike Investment--
SXTCChina SXT Pharmaceuticals--
SHPHShuttle Pharmaceuticals--

SBFM Revenue FAQ

What is Sunshine Biopharma’s yearly revenue?

Sunshine Biopharma's yearly revenue for 2023 was $39.85M, representing an increase of 816.94% compared to 2022. The company's yearly revenue for 2022 was $4.35M, representing an increase of 1802.41% compared to 2021. SBFM's yearly revenue for 2021 was $228.43K, representing an increase of 219.88% compared to 2020.

What is Sunshine Biopharma’s quarterly revenue?

Sunshine Biopharma's quarterly revenue for Q2 2024 was $9.3M, a 23.37% increase from the previous quarter (Q1 2024), and a 67.30% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $7.54M, a -1.81% decrease from the previous quarter (Q4 2023), and a 54.09% increase year-over-year (Q1 2023). SBFM's quarterly revenue for Q4 2023 was $7.68M, a 28.91% increase from the previous quarter (Q3 2023), and a 94.94% increase year-over-year (Q4 2022).

What is Sunshine Biopharma’s revenue growth rate?

Sunshine Biopharma's revenue growth rate for the last 3 years (2021-2023) was 17343.90%, and for the last 5 years (2019-2023) was 188557.75%.